Company
Stoke Therapeutics, Inc. (STOK)
Standardized SEC financial data for Stoke Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001623526 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-11.2%
Net margin
-3.7%
Revenue growth (YoY)
404.5%
Return on equity
-1.9%
Free cash flow
$44.9M
Current ratio
5.28×
EPS (diluted)
$-0.12
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $12.4M | $8.8M | $36.6M | $184.4M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $287.3M | $144.9M | $113.6M | $191.4M | $128.0M | $84.2M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$42.2M | -$66.9M | -$31.9M | -$81.1M | -$86.9M | $45.6M |
| Capital expenditures |
Get STOK data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/STOK/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/STOK/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"